HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages.

Abstract
Intense immunostaining for pregnancy-associated plasma protein-A (PAPP-A), a newly characterized metalloproteinase in the insulin-like growth factor system, colocalizes with activated macrophages in human atherosclerotic plaque. To determine macrophage regulation of PAPP-A expression, we developed two models of human macrophages with basal and activated phenotypes. THP-1 cells and peripheral blood monocytes could be differentiated into macrophages and activated upon specific treatment regimens with phorbol myristate acetate, macrophage colony-stimulating factor, and interleukin-1beta. Activation was assessed by cell secretion of tumor necrosis factor-alpha, which increased 30- to 100-fold with activation. Activated macrophages also secreted matrix metalloproteinase-9. However, no PAPP-A mRNA or PAPP-A antigen could be detected in these cells under any condition. Upon incubation with recombinant PAPP-A, we found that activated macrophages bound and internalized more PAPP-A than unactivated macrophages or monocytes. Internalization accounted for at least 50% of macrophage-associated PAPP-A, as assessed in studies with cytochalasin B. Membrane-bound PAPP-A retained protease activity, whereas internalized PAPP-A had little or no activity. Similar experiments carried out with a mutated variant of PAPP-A, which retains functionality as a protease but is unable to bind surface-associated glycosaminoglycan, showed no macrophage association or internalization. Absence of PAPP-A expression was confirmed in activated macrophages isolated from a hypercholesterolemic rabbit model of atherosclerosis. We therefore conclude that PAPP-A is not synthesized in, but rather is bound and internalized by, macrophages. Our findings likely account for the observed intense immunostaining for PAPP-A colocalizing with activated macrophages and may have physiological significance in the development of vulnerable plaque.
AuthorsCheryl A Conover, Sean C Harrington, Laurie K Bale, Claus Oxvig
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 292 Issue 2 Pg. H994-H1000 (Feb 2007) ISSN: 0363-6135 [Print] United States
PMID17040968 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Insulin-Like Growth Factor Binding Protein 4
  • Interleukin-1beta
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Macrophage Colony-Stimulating Factor
  • Pregnancy-Associated Plasma Protein-A
  • Matrix Metalloproteinase 9
  • Tetradecanoylphorbol Acetate
Topics
  • Animals
  • Atherosclerosis (etiology, metabolism)
  • Cell Differentiation (drug effects)
  • Cell Line
  • Disease Models, Animal
  • Endocytosis (drug effects)
  • Humans
  • Hypercholesterolemia (complications)
  • Insulin-Like Growth Factor Binding Protein 4 (metabolism)
  • Interleukin-1beta (pharmacology)
  • Macrophage Activation (drug effects)
  • Macrophage Colony-Stimulating Factor (metabolism)
  • Macrophages (cytology, drug effects, metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Mutation
  • Pregnancy-Associated Plasma Protein-A (genetics, metabolism)
  • Rabbits
  • Recombinant Proteins (pharmacology)
  • Tetradecanoylphorbol Acetate (pharmacology)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: